Focus In The Biotech Sector Could Soon Turn To These Therapeutic Areas And Companies

While vaccine makers have gotten most of the attention in the biotech sector over the past year, the author of today’s article advises that other therapeutic areas and companies could take the spotlight in the coming months, especially if the FDA’s recent approval of Biogen’s Alzheimer’s drug is indicative of the regulator taking a more friendly approach to approvals. For a look at the major biotech trends that are developing, and some of the names operating in those spaces, CLICK HERE.